Form D · Other Investment Fund

RPI US Partners II, LP

New York, NY · CIK 0001528095

Offering snapshot reported Apr 21, 2015 · SEC filing

Reported sold
$86.4M
Indefinite offering
Investors reported
48
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 13, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2015Initial$86,422,756No comparison48SEC filing
Aug 24, 2011Initial$544,753No comparison13SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-238352

Source: Form D, filed Apr 21, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

RPI US PARTNERS II, LP

Investment adviser: RP MANAGEMENT, LLC

Gross asset value
$415M
Beneficial owners
6
ADV minimum commitment
$0

Reported in Form ADV on Mar 30, 2021. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES WINDSOR, Connecticut, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor ERNST & YOUNG DUBLIN, Ireland
Custodian BANK OF AMERICA NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ERNST & YOUNG
PCAOB 1411

Filing source

Form ADV 1513828 · Mar 30, 2021 · Schedule D 7.B.(1), fund 805-8595434866

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pablo Legorreta Executive
N/A Pharmaceutical Investors, Lp Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
110 East 59 Th Street Suite 3300
New York, NY, 10022